Neurocognitive Impairment in Lead-Exposed Children of Andean Lead-Glazing Workers

OBJECTIVE: The level of lead (Pb) exposure necessary to induce intellectual impairment has not been firmly established. Some studies using conventional language-based intelligence tests have reported that pediatric blood lead (PbB) levels lower than 10 microg/dL (0.483 micromol/L) are associated with neurocognitive impairment. However, these tests may introduce cultural biases in the assessment of intellectual functioning. The objective of this study was to assess the effects of PbB concentration on nonverbal intelligence in Andean children with chronic environmental Pb exposure using a nonlanguage-based test of cognitive functioning. METHODS: Using Raven Colored Progressive Matrices (RCPM) as a measure of nonverbal intelligence, this study investigated the effects of Pb exposure (biomarker: PbB levels) on intellectual functioning in 188 chronically Pb-exposed children (age range: 5.33-11.67 years) of Ecuadorian Andean Pb-glazing workers. RESULTS: The mean PbB level of the 188 children was 29.3 microg/dL (range: 3.5-94.3 microg/dL). Forty-seven children had PbB levels or =10 microg/dL, 97 had abnormal RCPM scores. A regression analysis revealed a statistically significant negative association (r = -0.331, P 70 microg/dL. CONCLUSIONS: Performance on a test of nonverbal intelligence was inversely associated with chronic Pb exposure in Andean children with PbB levels below and above the CDC risk management level of 10 microg/dL, with the decline in test scores suggesting a dose-response relationship.